{
    "Overall_score": {
        "Correlation": 8,
        "Sentiment": 6,
        "Importance": 7,
        "Impact": 7,
        "Duration": 5,
        "Virality": 4,
        "Source_Score": 7,
        "Specificity": 8,
        "Sector_Spread": 9,
        "Tech_Mentions": 3
    },
    "Each_item": [
        {
            "News_content": "Nomura says $MRK $IDNX deal confirms #HCV market Worth north of $600bn $GILD $JNJ $ABBV $MVIRb",
            "Correlation": 9,
            "Sentiment": 7,
            "Importance": 8,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 10,
            "Tech_Mentions": 2
        },
        {
            "News_content": "Just when buyout speculation is rising, Achillion gets good news on the hepatitis C front: $ACHN $MRK $IDIX",
            "Correlation": 8,
            "Sentiment": 6,
            "Importance": 7,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 6,
            "Specificity": 8,
            "Sector_Spread": 8,
            "Tech_Mentions": 1
        },
        {
            "News_content": "Miss it? AM Anticipation 06/10 Futures dip despite strong Chinese data, jobs data awaits $DJIA $MRK $TSN",
            "Correlation": 6,
            "Sentiment": 4,
            "Importance": 5,
            "Impact": 5,
            "Duration": 4,
            "Virality": 3,
            "Source_Score": 5,
            "Specificity": 6,
            "Sector_Spread": 7,
            "Tech_Mentions": 2
        },
        {
            "News_content": "$MRK Why Gilead Sciences, Inc.( GILD) Lost its Ground after Merck & Co., Inc.( MRK)",
            "Correlation": 8,
            "Sentiment": 5,
            "Importance": 7,
            "Impact": 7,
            "Duration": 5,
            "Virality": 4,
            "Source_Score": 7,
            "Specificity": 8,
            "Sector_Spread": 8,
            "Tech_Mentions": 3
        },
        {
            "News_content": "$MRK Gilead Faces Stronger Hepatitis C Rival After Merck Deal",
            "Correlation": 9,
            "Sentiment": 6,
            "Importance": 8,
            "Impact": 8,
            "Duration": 6,
            "Virality": 5,
            "Source_Score": 8,
            "Specificity": 9,
            "Sector_Spread": 9,
            "Tech_Mentions": 3
        },
        {
            "News_content": "RT @LaMonicaBuzz: No profits? No problem for biotechs. Today's Buzz. With reference to Huey Lewis and the News. Naturally. $MRK $IDIX",
            "Correlation": 5,
            "Sentiment": 6,
            "Importance": 4,
            "Impact": 4,
            "Duration": 3,
            "Virality": 6,
            "Source_Score": 5,
            "Specificity": 5,
            "Sector_Spread": 6,
            "Tech_Mentions": 1
        }
    ]
}